RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
Common side effects include: Nausea Vomiting Diarrhea or constipation Headache Fatigue Serious but rare side effects may include: Pancreatitis Gallbladder issues Kidney injury (due to dehydration) Possible risk of thyroid C-cell tumors (seen in animal studies) Overall, when used under proper medical supervision and with regular monitoring, Semaglutide has shown a favorable safety profile, especially compared to traditional weight-loss drugs
Also called cobalamin, vitamin B12 plays a very important part in many critical body functions
Change the body, and the same milligrams land at a different occupancy and a different effect
Your B12 lab results at the 3-month check should guide this decision
GHK-Cu has shown protective effects on cartilage and bone cells in vitro, suggesting potential in joint or bone healing
